Podcast appearances and mentions of john stanford

In this Vital Health Podcast, John Stanford, Executive Director of Incubate, discusses the impact of the Inflation Reduction Act (IRA) on venture capital investments in life sciences. Stanford emphasizes that the IRA's price control mechanisms have led to significant shifts in funding, particularly away from small-molecule drug development, creating what is described as the "small molecule penalty." Key points include: Venture Capital's Role and Challenges: Venture capital is critical in translating basic research into medicines. The Inflation Reduction Act has disrupted this ecosystem, discouraging investment in certain drugs due to anticipated lower returns under price control regimes. Data from the Life Science Tracker: Stanford highlights the Life Science Tracker findings, showing 36 research programs and 21 specific drug developments discontinued since the IRA's passage. Notably, investments are markedly shifted from small molecules to biologics. Economic and Patient Impact: The IRA has led to reduced innovation in critical areas like oncology and rare diseases. Treatments for diseases like ovarian cancer and blindness have been deprioritized. Stanford argues that the act inadvertently penalizes older patients, the demographic it was designed to benefit, by disincentivizing drugs for age-related diseases. Proposed Solutions: The EPIC Act, a bipartisan effort supported by Incubate, aims to address the disparities by giving small molecules the same 13-year exclusivity period as biologics. Fixing the incentives for drug development, including addressing multiple indication penalties, is crucial to fostering innovation. Critique of Government Assessments: Stanford critiques the Congressional Budget Office (CBO) for its reliance on limited data sources and narrow time horizons, which fail to capture the long-term impacts of the IRA. In conclusion, Stanford stresses the need for legislative adjustments to mitigate the IRA's unintended consequences on drug innovation and patient care. For more insights, listeners are directed to the Life Science Tracker at lifesciencetracker.com.See omnystudio.com/listener for privacy information.

This Day in Legal History: James McCord ArrestedOn June 17, 1972, James McCord, security director for President Richard Nixon's re-election committee, and four Cuban-Americans were arrested for breaking into the Democratic National Committee Headquarters at the Watergate complex in Washington, D.C. This event marked the beginning of the Watergate scandal, a major political scandal in the United States that ultimately led to President Nixon's resignation. The burglars were caught wiretapping phones and stealing documents, intending to gather information to sabotage Nixon's political opponents. As investigations unfolded, it was revealed that the break-in was part of a broader campaign of political espionage and sabotage conducted by the Nixon administration. The scandal exposed widespread abuse of power, including illegal wiretapping, break-ins, and attempts to cover up these activities. Journalists Bob Woodward and Carl Bernstein of The Washington Post played a crucial role in uncovering the details of the scandal, leading to increased public scrutiny and pressure on the administration.The investigation led to the indictment of several Nixon administration officials and the creation of the Senate Watergate Committee. The most significant outcome was the discovery of the existence of secret tapes of conversations in the Oval Office, which revealed President Nixon's involvement in the cover-up. Faced with the likelihood of impeachment, Nixon became the first U.S. president to resign from office on August 8, 1974. The Watergate scandal had a lasting impact on American politics, leading to increased transparency and reforms aimed at preventing such abuses of power in the future.The rare disease community is advocating for changes to the Inflation Reduction Act's drug price-setting scheme, which is causing drugmakers and investors to reconsider developing drugs for small patient populations. Companies like Pfizer, Alnylam Pharmaceuticals, Eli Lilly, and Protagonist Therapeutics are altering their research strategies due to concerns over recouping costs under the Medicare Drug Price Negotiation Program. This program exempts orphan drugs with a single FDA-approved indication from price negotiations, but those with multiple indications might not qualify for the exclusion, even if they are not yet approved for additional conditions.Opponents are seeking legislative and judicial changes to amend the Inflation Reduction Act, as companies and investors shift their focus away from rare disease and small-molecule drugs. Jamie Sullivan of the EveryLife Foundation for Rare Diseases emphasized the importance of achieving technical fixes to support innovation. Recent legislative efforts aim to protect the development of these drugs, and companies like AstraZeneca are challenging the provisions in court. The Inflation Reduction Act has made the capital environment more challenging for rare disease drugs, according to John Stanford of the Incubate Coalition.Patient groups and some manufacturers argue that the exemption reduces incentives provided by the Orphan Drug Act, which has historically promoted the research and development of rare disease medicines. These drugs often launch with a single indication but can later be approved for additional uses. Concerns are rising that the current policies may hinder further research into rare diseases. Despite industry concerns, some groups argue that drug companies still have substantial resources for robust R&D and can profit from expanding indications for orphan drugs. A CMS spokesperson stated that the negotiation program aligns with the law and won't harm long-term innovation.US Drug Negotiations Plan Shifts Focus for Rare Disease ProgramsAlex Jones' personal bankruptcy has been converted to a Chapter 7 liquidation, meaning a trustee will now manage how he pays the $1.5 billion in defamation judgments against him. Jones was unable to reach an agreement with the families of the Sandy Hook Elementary School shooting victims, whom he defamed by claiming the 2012 massacre was a hoax. US Bankruptcy Judge Christopher Lopez ruled that Jones' case does not qualify for exceptions to prevent its conversion to Chapter 7, despite Jones' objections.During the same hearing, Judge Lopez dismissed the bankruptcy case of Infowars' parent company, Free Speech Systems LLC, allowing the Sandy Hook families to pursue their claims in state court. The judge clarified that there was never a request to shut down Infowars itself. Lopez expressed the difficulty of the case, acknowledging its connection to the tragic 2012 shooting.Jones' defamation debts were deemed non-dischargeable in bankruptcy due to the intentional and malicious nature of his actions. Following state court verdicts, Free Speech Systems filed for Chapter 11 bankruptcy in July 2022, and Jones filed for personal bankruptcy in December 2022. Efforts to reach a consensual bankruptcy plan failed, prompting the recent conversion to Chapter 7.Jones and the Sandy Hook families had recently agreed on the need to convert his case to Chapter 7, but the Free Speech Systems case remained contentious. Ultimately, the court decided that dismissing the Free Speech case was in the best interest of creditors. Despite potential liquidation, Jones may start a new broadcast, according to attorneys for the Sandy Hook families. This case is being managed under Alexander E. Jones, Bankr. S.D. Tex., No. 22-33553, as of June 14, 2024.Alex Jones Loses Financial Control as Trustee Takes Over (4)Alex Jones' assets to be liquidated as his company exits bankruptcy | ReutersAt a star-studded fundraiser in Los Angeles on June 15, President Joe Biden criticized the U.S. Supreme Court as being "out of kilter," emphasizing that it has never been as out of step as it is today. The event, which featured former President Barack Obama and Hollywood celebrities like George Clooney and Julia Roberts, raised over $30 million for Biden's campaign. Biden highlighted the court's conservative leanings, particularly criticizing Justice Clarence Thomas's remarks on reconsidering issues like in vitro fertilization and contraception. He also warned that if Donald Trump wins the 2024 election, he could appoint two more justices, which Biden described as alarming.The fundraiser was framed by a video montage contrasting Biden's record with that of Trump, drawing cheers from the audience. Biden noted that the Supreme Court, now dominated by conservatives appointed by Trump, has made decisions restricting affirmative action, gay rights, gun control, and environmental regulations. Obama reiterated the importance of elections in determining the court's power, linking the current situation to Trump's 2016 victory.The event marked the largest Democratic fundraiser in history, surpassing a previous record set in New York City. Other celebrities present included Jack Black, Jason Bateman, and Kathryn Hahn. Despite Biden's low approval ratings and concerns about his age, the fundraiser aimed to showcase the campaign's strength and momentum. Biden and Trump are currently tied in national polls, with Trump leading in battleground states. Both candidates have raised significant funds in California, demonstrating the state's financial influence on their campaigns.Biden slams Supreme Court at $30 million fundraiser with Obama, Clooney, Julia Roberts | Reuters This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.minimumcomp.com/subscribe

In this episode of Seattle Hall Pass, we cover the recent teacher reallocations at elementary schools. We explain the upheaval at elementary schools, as Seattle Public Schools shifts teachers and students among classes in order to be compliant with a state law.For sources on the facts cited in the podcast and other supporting documentation, see our show notes here.We want to hear from our listeners. Email us with comments, questions, or corrections at hello@seattlehallpass.org.Support the showMusic by Sarah, the Illstrumentalist, logo by Carmen Lau-Woo

John Stanford with Incubate explains how the Inflation Reduction Act has already begun to deter investments in drug research and development; Patients Rising issues a statement calling for progress on several key healthcare issues, including PBMs; and a new white paper from Sen. Bill Cassidy looks at the impacts of AI on healthcare, including patient privacy.  Incubate Webpage Axios: Drugmakers, investors say they've already changed bets in IRA's first year Patients Rising Now Webpage: Patients Rising Now Issues ‘Must Pass for Patients' List for Congress Ranking Member Cassidy Releases White Paper on Artificial Intelligence Listen: AI Privacy Concerns + Accelerated Approval Benefits  

It's been a rough year for the markets, with the Nasdaq down nearly 34% and mega-cap tech stocks seeing major losses across the board. Evercore ISI's Mark Mahaney breaks down the tech trade. Plus, there's been a lot of optimism among investors over China and the reopening of the world's second largest economy as the government works to scrap its long-held Zero Covid policy. MSA Capital's Ben Harburg discusses the latest. And, it's not just big corporation that have been tightening their belts due to fears of inflation and a potential recession - it's also small businesses. Small Business Roundtable's John Stanford explains the outlook.

We'll be the first to say that the healthcare system is broken, especially in patient access complexity.However, we see three areas where we can execute actionable change for patients in 2022: intellectual property, mergers and acquisitions, and the FDA's reauthorization.In this episode, Coalition Manager and podcast host Ashlyn Roberts interviews John Stanford, Executive Director at Incubate Coalition, about opportunities for pro-patient reform.Join us as we discuss:A level set of what's been happening in Washington latelyWhy drug pricing issues are still evergreen3 areas for improvement: IP, M&A, and PDUFAShifting the narrative about pro-patient reformsAs we continue this journey together, we want to hear from you, the listener. Email John@incubatecoalition.org or Ashlyn@incubatecoalition.org what's top of mind, what story you want to hear, or what you find interesting!To hear more interviews like this one, subscribe to Making Medicine on Apple Podcasts, Spotify, or your preferred podcast platform.Listening on a desktop & can't see the links? Just search for Making Medicine in your favorite podcast player.

Elon Musk is no longer joining the board of Twitter, says the CEO. So what does it mean for the stock, for Musk, and for the company? We discuss with Jon Najarian and The Guardian's Alex Hern. Plus, it's a big week for inflation data, the first to show the impacts of the war on global pricing. And we check in on the state of small business with Small Business Roundtable's John Stanford, on the heels of employment data out of the NFIB.

New Jersey saw Covid cases rise 42% in one day due to omicron. Dr. Shereef Elnahal, CEO of University Hospital, Newark, joins with an on-the-ground look at hospital rates. Plus, the holidays are a critical time for small businesses, but have omicron and the supply chain thrown a wrench into revenue? John Stanford of the Small Business Roundtable joins with a barometer of the sector. And we're coming up on the “Santa Claus rally” period, AKA the last five trading days of this year with the first two of next year. Jeff Kilburg and Delano Saporu tell us what they're watching in the markets.

John Stanford of the Small Business Roundtable joins to discuss their latest report with Facebook about the state of small business and the path to economic recovery. Plus, natural gas prices are spiking—we speak with Rystad's Emily McClain about how it could impact you. And on the eve of the 20th anniversary of the 9/11 attacks, our own Ylan Mui joins with a report on the first responders who suffered lifelong illnesses from that day, and where they're getting help.

Intellectual property (IP) rights have been the driving force behind innovation and entrepreneurship. However, IP has more recently been seen in a negative light.Through the COVID-19 Pandemic, vaccine IP rights have come into question: should IP rights be waived when concerning an essential technology? Andrei Iancu, Former Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office, joins the podcast to discuss his views and concerns on IP rights:What we talked about:- The Benefits of IP- How Sentiment of IP Has Changed- Short, Medium, & Long Term Concerns to Waiving IP Rights- Where Concerns Should Be Focused & How to Improve IPCheck out the resources below for more information:- Andrei's LinkedIn- Our host: John Stanford's LinkedIn- www.incubatecoalition.comTo hear more interviews like this one, subscribe to Making Medicine on Apple Podcasts, Spotify, or your preferred podcast platform.

The fight against Antimicrobial Resistance (AMR) is challenging due to financial, ethical, and legislative issues. Combating infectious disease can prove to be a risky financial investment but much less in comparison to the global impact if solutions are not researched. Alfonso Chang is the Managing Director of Relativity Healthcare Partners; he shares insight into the challenges and how to overcome them:- Investor Hesitancy- Higher clinical and ethical implications- Preference of existing therapies over new ones- Unintended consequences from lawmakers due to drafted legislative languageCheck out the resources below for more information:- Alfonso's LinkedIn- Our host: John Stanford's LinkedInTo hear more interviews like this one, subscribe to Making Medicine on Apple Podcasts, Spotify, or your preferred podcast platform.

From chance meetings to risky investments, Making Medicine explores the origin stories of life changing medication and how patients, corporations and investment communities benefit from understanding it. On today's episode, Kelsey Kohrs, Producer at Sweet Fish Media and John Stanford, Executive Director of Incubate Coalition introduce Making Medicine, a podcast dedicated to sharing life science stories that have led to scientific breakthroughs. These stories will cover:- What are the different steps of the drug development process?- How can we sustain future innovation in the life sciences?-When chance meetings have led to life changing drug innovationAs we begin on this new journey together, we would love to hear from you, the listener. What's interesting? What do you want to hear more of? Is there a story that you've heard of that you'd like our team to dig in to? Email John@incubatecoalition.org or Ashlyn@incubatecoalition.org.To hear more interviews like this one, subscribe to Making Medicine on Apple Podcasts, Spotify, or your preferred podcast platform.

In 1980, the Bayh-Dole Act was enacted by U.S. Congress, which changed how ownership of an invention is pursued. Almost 40 years later, how has this act fared?On Episode 1 of Making Medicine, John Stanford, Executive Director of Incubate Coalition, introduces Joseph Allen and Associates to cover:- How Bayh-Dole came to be, starting with Purdue University - The original intent of ‘march-in' rights and how it affects Bayh-Dole- Who was this act for, and how has it played out 40 years later?As we begin on this new journey together, we would love to hear from you, the listener. Email John@incubatecoalition.org or Ashlyn@incubatecoalition.org what's top of mind, what story you want to hear, or what you find interesting!To hear more interviews like this one, subscribe to Making Medicine on Apple Podcasts, Spotify, or your preferred podcast platform.

Small business closures have risen since the peak of the pandemic. We discuss with Small Business Roundtable’s John Stanford. Plus, the U.S. is about to have a new airline—Phil Lebeau has the latest. And does the future of fitness lie in the home? We speak with Future CEO Rishi Mandal about the trends here to stay.

Con demasiada frecuencia percibimos que, a pesar de todos nuestros esfuerzos, no conseguimos controlar todo aquello que nos proponemos. El tiempo se nos escapa, nuestros proyectos no salen como pretendemos o los posponemos eternamente. No acabamos de concretar aquella cita, aquel encuentro que realmente deseamos. Nos empeñamos firmemente en nuestros objetivos, pero una y otra vez surgen múltiples complicaciones que nos apartan de conseguirlos. En cierta medida es como si intentáramos atrapar las nubes con nuestras manos... Hoenix, Gabriel Saban, Hinako Omori, Rival Consoles, Ryan Teague, John Stanford, Stefania Avolio, Leifur James, Vangelis, Murya, Ignacio Núñez.

John is a student at the Stanford Medicine Master of Science in PA Studies (MSPA) program. He talks about how all his experiences led him to think about the profession of PA and what made his application strong for the Stanford Medicine MSPA program. John offers great information and advice for all the students who are thinking of a career as a PA.

Highlights from the IPSASB CAG December 2019 meeting in Abu Dhabi, United Arab Emirates: 00:11 Welcome and introduction: John Stanford, IPSASB Technical Director01:05 Chair’s summary of the IPSASB CAG meeting: Thomas Müller-Marqués Berger, IPSASB CAG Chair14:12 Closing remarks: John Stanford, IPSASB Technical Director

Highlights from the IPSASB CAG December 2019 meeting in Abu Dhabi, United Arab Emirates: 00:11 Welcome and introduction: John Stanford, IPSASB Technical Director01:05 Chair’s summary of the IPSASB CAG meeting: Thomas Müller-Marqués Berger, IPSASB CAG Chair14:12 Closing remarks: John Stanford, IPSASB Technical Director

Highlights from the IPSASB CAG December 2019 meeting in Abu Dhabi, United Arab Emirates: 00:11     Welcome and introduction: John Stanford, IPSASB Technical Director01:05     Chair’s summary of the IPSASB CAG meeting: Thomas Müller-Marqués Berger, IPSASB CAG Chair14:12     Closing remarks: John Stanford, IPSASB Technical Director

Highlights from the IPSASB December 2019 meeting in Abu Dhabi, United Arab Emirates:00:10     Welcome and introduction: John Stanford, Technical Director01:02     Chair’s meeting overview: Ian Carruthers, IPSASB Chair03:02     Revenue with Performance Obligations: Edwin Ng, Principal04:04     Revenue without Performance Obligations: Joanna Spencer, Manager04:56     Transfer Expenses: Paul Mason, Senior Advisor06:06     Leases: João Carlos Fonseca, Principal06:52     Measurement: Dave Warren, Principal09:46     Chair’s concluding comments: Ian Carruthers, IPSASB Chair12:54     Closing remarks: John Stanford, Technical Director

Highlights from the IPSASB December 2019 meeting in Abu Dhabi, United Arab Emirates:00:10 Welcome and introduction: John Stanford, Technical Director01:02 Chair’s meeting overview: Ian Carruthers, IPSASB Chair03:02 Revenue with Performance Obligations: Edwin Ng, Principal04:04 Revenue without Performance Obligations: Joanna Spencer, Manager04:56 Transfer Expenses: Paul Mason, Senior Advisor06:06 Leases: João Carlos Fonseca, Principal06:52 Measurement: Dave Warren, Principal09:46 Chair’s concluding comments: Ian Carruthers, IPSASB Chair12:54 Closing remarks: John Stanford, Technical Director

Highlights from the IPSASB CAG December 2019 meeting in Abu Dhabi, United Arab Emirates: 00:11 Welcome and introduction: John Stanford, IPSASB Technical Director01:05 Chair’s summary of the IPSASB CAG meeting: Thomas Müller-Marqués Berger, IPSASB CAG Chair14:12 Closing remarks: John Stanford, IPSASB Technical Director

Highlights from the IPSASB June 2019 meeting in Toronto, Canada:00:10     Welcome and introduction: John Stanford, Technical Director01:06     Chair’s meeting overview: Ian Carruthers, Chair02:52     Public Sector Specific Financial Instruments: Dave Warren, Principal03:58     Revenue with Performance Obligations: Amon Dhliwayo, Manager05:30     Revenue without Performance Obligations: Joanna Spencer, Manager06:36     Expenses: Paul Mason, Consultant08:15     Leases: Ian Carruthers, Chair11:38     Chair’s concluding comments: Ian Carruthers, Chair13:23     Closing remarks: John Stanford, Technical Director

Highlights from the IPSASB June 2019 meeting in Toronto, Canada:00:10 Welcome and introduction: John Stanford, Technical Director01:06 Chair’s meeting overview: Ian Carruthers, Chair02:52 Public Sector Specific Financial Instruments: Dave Warren, Principal03:58 Revenue with Performance Obligations: Amon Dhliwayo, Manager05:30 Revenue without Performance Obligations: Joanna Spencer, Manager06:36 Expenses: Paul Mason, Consultant08:15 Leases: Ian Carruthers, Chair11:38 Chair’s concluding comments: Ian Carruthers, Chair13:23 Closing remarks: John Stanford, Technical Director

Highlights from the IPSASB March 2019 meeting in Washington DC.00:11      Welcome and introduction: John Stanford, Technical Director01:09      Chair’s overview of outreach event co-hosted with the World Bank and the International Monetary Fund, Leveraging Financial Reporting for Fiscal Reporting and Management of Public Wealth: Ian Carruthers, Chair03:30      Chair’s meeting overview: Ian Carruthers, Chair05:47      Measurement: Dave Warren, Principal06:49      Revenue from Binding Arrangements with Purchasers: Amon Dhliwayo, Manager07:38      Revenue – Enforceability and Performance Obligations: Joanna Spencer, Manager08:40      Chair’s concluding comments: Ian Carruthers, Chair12:04      Closing remarks: John Stanford, Technical Director

Highlights from the IPSASB March 2019 meeting in Washington DC.00:11 Welcome and introduction: John Stanford, Technical Director01:09 Chair’s overview of outreach event co-hosted with the World Bank and the International Monetary Fund, Leveraging Financial Reporting for Fiscal Reporting and Management of Public Wealth: Ian Carruthers, Chair03:30 Chair’s meeting overview: Ian Carruthers, Chair05:47 Measurement: Dave Warren, Principal06:49 Revenue from Binding Arrangements with Purchasers: Amon Dhliwayo, Manager07:38 Revenue – Enforceability and Performance Obligations: Joanna Spencer, Manager08:40 Chair’s concluding comments: Ian Carruthers, Chair12:04 Closing remarks: John Stanford, Technical Director

Highlights from the CAG's December 3, 2018 meeting in Kuala Lumpur.00:11 Welcome and introduction: John Stanford, IPSASB Technical Director00:54 Chair’s summary of the IPSASB CAG meeting: Thomas Müller-Marqués Berger, IPSASB CAG Chair09:38 Closing remarks: John Stanford, IPSASB Technical Director

Highlights from the CAG's December 3, 2018 meeting in Kuala Lumpur.00:11 Welcome and introduction: John Stanford, IPSASB Technical Director00:54 Chair’s summary of the IPSASB CAG meeting: Thomas Müller-Marqués Berger, IPSASB CAG Chair09:38 Closing remarks: John Stanford, IPSASB Technical Director

Highlights from the CAG's December 3, 2018 meeting in Kuala Lumpur.00:11     Welcome and introduction: John Stanford, IPSASB Technical Director00:54     Chair’s summary of the IPSASB CAG meeting: Thomas Müller-Marqués Berger, IPSASB CAG Chair09:38     Closing remarks: John Stanford, IPSASB Technical Director

Highlights from the CAG's December 3, 2018 meeting in Kuala Lumpur.00:11 Welcome and introduction: John Stanford, IPSASB Technical Director00:54 Chair’s summary of the IPSASB CAG meeting: Thomas Müller-Marqués Berger, IPSASB CAG Chair09:38 Closing remarks: John Stanford, IPSASB Technical Director

Highlights from the CAG's December 3, 2018 meeting in Kuala Lumpur.00:11     Welcome and introduction: John Stanford, IPSASB Technical Director00:54     Chair’s summary of the IPSASB CAG meeting: Thomas Müller-Marqués Berger, IPSASB CAG Chair09:38     Closing remarks: John Stanford, IPSASB Technical Director

Highlights from the IPSASB's December 4-7 meeting in Kuala Lumpur.00:10 Welcome and introduction: John Stanford, Technical Director00:56 Chair’s meeting overview: Ian Carruthers, IPSASB Chair02:40 Social Benefits, Collective and Individual Services, and Emergency Relief: Paul Mason, Principal04:20 Revenue (IFRS 15 Alignment) and Amendments to IPSAS 36 and IPSAS 41: Amon Dhliwayo, Manager05:20 Grants and Transfers (Time requirements): Joanna Spencer, Manager06:23 Leases: Joao Carlos Fonseca, Principal07:34 Approval of Strategy and Work Plan: Ross Smith, Deputy Director08:40 Chair’s concluding comments: Ian Carruthers, IPSASB Chair11:05 Closing remarks: John Stanford, Technical Director

Highlights from the IPSASB's December 4-7 meeting in Kuala Lumpur.00:10 Welcome and introduction: John Stanford, Technical Director00:56 Chair’s meeting overview: Ian Carruthers, IPSASB Chair02:40 Social Benefits, Collective and Individual Services, and Emergency Relief: Paul Mason, Principal04:20 Revenue (IFRS 15 Alignment) and Amendments to IPSAS 36 and IPSAS 41: Amon Dhliwayo, Manager05:20 Grants and Transfers (Time requirements): Joanna Spencer, Manager06:23 Leases: Joao Carlos Fonseca, Principal07:34 Approval of Strategy and Work Plan: Ross Smith, Deputy Director08:40 Chair’s concluding comments: Ian Carruthers, IPSASB Chair11:05 Closing remarks: John Stanford, Technical Director

John Stanford, managing partner of Prism Group (www.PrismGroup.Global) and executive director of the Small Business Roundtable in Washington DC (SmallBusinessRoundtable.org), joins us to give a report on current business issues from the nation's capital. by SBE Council on ForbesBooks Radio

Highlights from the IPSASB's June 19 - 22, 2018 meeting in Toronto.0:10 -- Welcome and introduction: John Stanford, IPSASB Technical Director1:19 -- Chair’s meeting overview: Ian Carruthers, IPSASB Chair2:39 -- Financial Instruments: Dave Warren, IPSASB Manager, Standards Development and Technical Projects,4:43 -- Social Benefits and Non-Exchange Expenses: Paul Mason, IPSASB Principal6:39 – Revenue: Amon Dhliwayo & Joanna Spencer, IPSASB Managers, Standards Development and Technical Projects,8:50 -- Strategy and Work Plan Roundtables: Ross Smith, Deputy Director10:18 -- Chair’s closing comments: Ian Carruthers, IPSASB Chair11:19 -- Closing remarks: John Stanford, IPSASB Technical Director

Highlights from the IPSASB's June 19 - 22, 2018 meeting in Toronto.0:10 -- Welcome and introduction: John Stanford, IPSASB Technical Director1:19 -- Chair’s meeting overview: Ian Carruthers, IPSASB Chair2:39 -- Financial Instruments: Dave Warren, IPSASB Manager, Standards Development and Technical Projects,4:43 -- Social Benefits and Non-Exchange Expenses: Paul Mason, IPSASB Principal6:39 – Revenue: Amon Dhliwayo & Joanna Spencer, IPSASB Managers, Standards Development and Technical Projects,8:50 -- Strategy and Work Plan Roundtables: Ross Smith, Deputy Director10:18 -- Chair’s closing comments: Ian Carruthers, IPSASB Chair11:19 -- Closing remarks: John Stanford, IPSASB Technical Director

Highlights from the IPSASB's September 19 - 22, 2017, meeting in Toronto, Canada. 0:11 -- Introduction and welcome (John Stanford, Technical Director)0:50 -- Overview of meeting (Ian Carruthers, Chair)3:44 -- Strategy and Work Plan (Ross Smith, Deputy Director)5:01 -- Social Benefits (Paul Mason, Principal)8:06 -- Cash Basis IPSAS (Joanna Spencer, Manager, Standards Development and Technical Projects)9:21 -- Leases (João Fonseca, Manager, Standards Development and Technical Projects)11:12 -- Final thoughts (Ian Carruthers, Chair)12:26 -- Closing remarks (John Stanford, Technical Director)

Highlights from the IPSASB's September 19 - 22, 2017, meeting in Toronto, Canada. 0:11   --   Introduction and welcome (John Stanford, Technical Director)0:50   --   Overview of meeting (Ian Carruthers, Chair)3:44   --   Strategy and Work Plan (Ross Smith, Deputy Director)5:01   --   Social Benefits (Paul Mason, Principal)8:06   --   Cash Basis IPSAS (Joanna Spencer, Manager, Standards Development and Technical Projects)9:21   --   Leases (João Fonseca, Manager, Standards Development and Technical Projects)11:12  --  Final thoughts (Ian Carruthers, Chair)12:26  --  Closing remarks (John Stanford, Technical Director)

Highlights from the IPSASB CAG's June 26, 2017, meeting in Luxemburg, Luxemburg. 0:10 – Introduction (John Stanford, Technical Director, IPSASB) 0:27 – Summary of IPSASB CAG meeting (Thomas Müller-Marqués Berger, IPSASB CAG Chair) 8:50 – Closing remarks (John Stanford, Technical Director, IPSASB)

Highlights from the IPSASB's June 27 - 30, 2017, meeting in Luxembourg, Luxembourg. 0:10 – Introduction (John Stanford, Technical Director, IPSASB) 1:13 – Overview of IPSASB meeting (Ian Carruthers, IPSASB Chair) 2:54 – Revenue and Non-Exchange Expenses (Jo Spencer, Standards Development & Technical Projects, IPSASB) 5:47 – Financial Instruments (Dave Warren, Principal, Public Sector Accounting Board, Canada) 6:54 – Social Benefits (Paul Mason, Principal, IPSASB) 7:58 – Strategy and Work Plan (Ian Carruthers, IPSASB Chair) 11:05 – Closing remarks (John Stanford, Technical Director, IPSASB)

Highlights from the IPSASB CAG's June 26, 2017, meeting in Luxemburg, Luxemburg. 0:10 – Introduction (John Stanford, Technical Director, IPSASB) 0:27 – Summary of IPSASB CAG meeting (Thomas Müller-Marqués Berger, IPSASB CAG Chair) 8:50 – Closing remarks (John Stanford, Technical Director, IPSASB)

Highlights from the IPSASB's June 27 - 30, 2017, meeting in Luxembourg, Luxembourg. 0:10 – Introduction (John Stanford, Technical Director, IPSASB) 1:13 – Overview of IPSASB meeting (Ian Carruthers, IPSASB Chair) 2:54 – Revenue and Non-Exchange Expenses (Jo Spencer, Standards Development & Technical Projects, IPSASB) 5:47 – Financial Instruments (Dave Warren, Principal, Public Sector Accounting Board, Canada) 6:54 – Social Benefits (Paul Mason, Principal, IPSASB) 7:58 – Strategy and Work Plan (Ian Carruthers, IPSASB Chair) 11:05 – Closing remarks (John Stanford, Technical Director, IPSASB)

In this installment of the Lubetkin on Communications Podcast, we present a panel discussion recorded July 12, 2016 at Temple University in Philadelphia. The panel, co-sponsored by the National Press Photographers Association (NPPA), the Society of Professional Journalists, and the Reporters' Committee for Freedom of the Press, focused on the upcoming Democratic National Convention, and was intended to brief journalists on their rights to make photos and video recordings during the expected street demonstrations and protests at the convention. Mickey H. Osterreicher, General Counsel, National Press Photographers Association, poses with @PodcastSteve after the NPPA's DNC Seminar in Philadelphia. (Shelly Lubetkin Photo) We reached out to Mickey H. Osterreicher, General Counsel, National Press Photographers Association, and offered our services to produce this podcast for An expert panel discussion regarding First Amendment rights: What are the rights of citizens and the press to photograph and record in public? Can police seize and view those images or order them to be deleted? What is some of the most recent case law regarding these issues? How can we foster a better understanding of our respective rights and responsibilities in order to have a greater respect for the roles that everyone plays in newsgathering and free speech? Journalists, lawyers, law enforcement officers as well as journalism, criminal justice & law students are all encouraged to attend.                                                                        Moderator: Mickey H. Osterreicher, General Counsel, National Press Photographers Association Panelists: David Boardman, Dean, Temple University, School of Media and Communication Francis T. Healy, Special Advisor to the COmmissioner, Philadelphia Police Dept. Lt. John Stanford, Public Information Officer, Philadelphia Police Dept. Gregg Leslie, Legal Defense Director, Reporters Committee for Freedom of the Press Gayle C. Sproul, Partner, Levine Sullivan Koch & Schulz, LLP Joseph Gidjunis, Independent Photojournalist Jim MacMillan, Independent Photojournalist and Program Manager, Temple University Center for Public Interest Journalism

foreign language immersion classes, teaching in a foreign language, learning math and science in a foreign language, the arts, international awareness, parental involvement, multicultural awareness, multicultural, multi-cultural, cultural, global

Highlights from the IPSASB's June 27 - 30, 2017, meeting in Luxembourg, Luxembourg.0:10 – Introduction (John Stanford, Technical Director, IPSASB)1:13 – Overview of IPSASB meeting (Ian Carruthers, IPSASB Chair)2:54 – Revenue and Non-Exchange Expenses (Jo Spencer, Standards Development & Technical Projects, IPSASB)5:47 – Financial Instruments (Dave Warren, Principal, Public Sector Accounting Board, Canada)6:54 – Social Benefits (Paul Mason, Principal, IPSASB)7:58 – Strategy and Work Plan (Ian Carruthers, IPSASB Chair)11:05 – Closing remarks (John Stanford, Technical Director, IPSASB)

Highlights from the IPSASB December 2019 meeting in Abu Dhabi, United Arab Emirates:00:10     Welcome and introduction: John Stanford, Technical Director01:02     Chair's meeting overview: Ian Carruthers, IPSASB Chair03:02     Revenue with Performance Obligations: Edwin Ng, Principal04:04     Revenue without Performance Obligations: Joanna Spencer, Manager04:56     Transfer Expenses: Paul Mason, Senior Advisor06:06     Leases: João Carlos Fonseca, Principal06:52     Measurement: Dave Warren, Principal09:46     Chair's concluding comments: Ian Carruthers, IPSASB Chair12:54     Closing remarks: John Stanford, Technical Director

Highlights from the IPSASB CAG's June 26, 2017, meeting in Luxembourg, Luxembourg.0:10 – Introduction (John Stanford, Technical Director, IPSASB)0:27 – Summary of IPSASB CAG meeting (Thomas Müller-Marqués Berger, IPSASB CAG Chair)8:50 – Closing remarks (John Stanford, Technical Director, IPSASB)

Highlights from the IPSASB's September 19 - 22, 2017, meeting in Toronto, Canada. 0:11   --   Introduction and welcome (John Stanford, Technical Director)0:50   --   Overview of meeting (Ian Carruthers, Chair)3:44   --   Strategy and Work Plan (Ross Smith, Deputy Director)5:01   --   Social Benefits (Paul Mason, Principal)8:06   --   Cash Basis IPSAS (Joanna Spencer, Manager, Standards Development and Technical Projects)9:21   --   Leases (João Fonseca, Manager, Standards Development and Technical Projects)11:12  --  Final thoughts (Ian Carruthers, Chair)12:26  --  Closing remarks (John Stanford, Technical Director)

Highlights from the IPSASB's June 19 - 22, 2018 meeting in Toronto.0:10 -- Welcome and introduction: John Stanford, IPSASB Technical Director1:19 -- Chair's meeting overview: Ian Carruthers, IPSASB Chair2:39 -- Financial Instruments: Dave Warren, IPSASB Manager, Standards Development and Technical Projects,4:43 -- Social Benefits and Non-Exchange Expenses: Paul Mason, IPSASB Principal6:39 – Revenue: Amon Dhliwayo & Joanna Spencer, IPSASB Managers, Standards Development and Technical Projects,8:50 -- Strategy and Work Plan Roundtables: Ross Smith, Deputy Director10:18 -- Chair's closing comments: Ian Carruthers, IPSASB Chair11:19 -- Closing remarks: John Stanford, IPSASB Technical Director

Highlights from the IPSASB's December 4-7 meeting in Kuala Lumpur.00:10 Welcome and introduction: John Stanford, Technical Director00:56 Chair's meeting overview: Ian Carruthers, IPSASB Chair02:40 Social Benefits, Collective and Individual Services, and Emergency Relief: Paul Mason, Principal04:20 Revenue (IFRS 15 Alignment) and Amendments to IPSAS 36 and IPSAS 41: Amon Dhliwayo, Manager05:20 Grants and Transfers (Time requirements): Joanna Spencer, Manager06:23 Leases: Joao Carlos Fonseca, Principal07:34 Approval of Strategy and Work Plan: Ross Smith, Deputy Director08:40 Chair's concluding comments: Ian Carruthers, IPSASB Chair11:05 Closing remarks: John Stanford, Technical Director

Highlights from the CAG's December 3, 2018 meeting in Kuala Lumpur.00:11     Welcome and introduction: John Stanford, IPSASB Technical Director00:54     Chair's summary of the IPSASB CAG meeting: Thomas Müller-Marqués Berger, IPSASB CAG Chair09:38     Closing remarks: John Stanford, IPSASB Technical Director

Highlights from the IPSASB March 2019 meeting in Washington DC.00:11      Welcome and introduction: John Stanford, Technical Director01:09      Chair's overview of outreach event co-hosted with the World Bank and the International Monetary Fund, Leveraging Financial Reporting for Fiscal Reporting and Management of Public Wealth: Ian Carruthers, Chair03:30      Chair's meeting overview: Ian Carruthers, Chair05:47      Measurement: Dave Warren, Principal06:49      Revenue from Binding Arrangements with Purchasers: Amon Dhliwayo, Manager07:38      Revenue – Enforceability and Performance Obligations: Joanna Spencer, Manager08:40      Chair's concluding comments: Ian Carruthers, Chair12:04      Closing remarks: John Stanford, Technical Director

Highlights from the IPSASB June 2019 meeting in Toronto, Canada:00:10     Welcome and introduction: John Stanford, Technical Director01:06     Chair's meeting overview: Ian Carruthers, Chair02:52     Public Sector Specific Financial Instruments: Dave Warren, Principal03:58     Revenue with Performance Obligations: Amon Dhliwayo, Manager05:30     Revenue without Performance Obligations: Joanna Spencer, Manager06:36     Expenses: Paul Mason, Consultant08:15     Leases: Ian Carruthers, Chair11:38     Chair's concluding comments: Ian Carruthers, Chair13:23     Closing remarks: John Stanford, Technical Director

Highlights from the IPSASB CAG December 2019 meeting in Abu Dhabi, United Arab Emirates: 00:11     Welcome and introduction: John Stanford, IPSASB Technical Director01:05     Chair's summary of the IPSASB CAG meeting: Thomas Müller-Marqués Berger, IPSASB CAG Chair14:12     Closing remarks: John Stanford, IPSASB Technical Director